Related Experiment Videos
IgA-dependent, monocyte-mediated, antibacterial activity
Abstract:
IgA purified from the sera of patients convalescing from disseminated group C meningococcal disease induced human monocyte-mediated anti-meningococcal activity in vitro in the absence of complement. Both IgA- and IgG-dependent activity were directed against the group C meningococcal polysaccharide (Csss) capsule. The amount of IgA that was effective bound less than 1 ng of Csss. Antibacterial activity was dependent upon the length and the temperature of the test incubation and on the concentration of monocytes. The implications of this mechanism for local cell-mediated antibacterial immunity are discussed.
Insights
Immunoglobulin A (IgA) from recovered patients fights Group C meningococcal bacteria. This antibody-mediated immunity occurs without complement, highlighting a key defense mechanism against bacterial meningitis.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Disseminated Group C meningococcal disease poses a significant public health threat.
- Understanding the mechanisms of host defense against Neisseria meningitidis is crucial for developing effective treatments and vaccines.
- The role of immunoglobulin A (IgA) in combating bacterial infections, particularly in the absence of complement, requires further elucidation.
Purpose of the Study:
- To investigate the in vitro anti-meningococcal activity induced by purified IgA from convalescent patients.
- To determine if this activity is complement-dependent or mediated by other host factors.
- To characterize the target of IgA-mediated antibacterial action on Group C meningococcal bacteria.
Main Methods:
- Purification of IgA from the sera of patients who recovered from disseminated Group C meningococcal disease.
- In vitro assays to assess the anti-meningococcal activity of purified IgA against Group C Neisseria meningitidis.
- Experiments conducted in the absence of complement to evaluate IgA's intrinsic antibacterial capabilities.
- Quantification of IgA binding to the Group C polysaccharide (Csss) capsule.
- Analysis of the influence of incubation time, temperature, and monocyte concentration on antibacterial activity.
Main Results:
- Purified IgA induced human monocyte-mediated anti-meningococcal activity in vitro, independent of complement.
- Both IgA- and IgG-dependent activities were specifically directed against the Group C meningococcal polysaccharide (Csss) capsule.
- Effective concentrations of IgA required minimal binding to the Csss capsule (less than 1 ng).
- Antibacterial activity demonstrated a dependency on incubation length, temperature, and monocyte concentration.
Conclusions:
- IgA plays a significant role in combating disseminated Group C meningococcal disease through complement-independent, monocyte-mediated mechanisms.
- The findings suggest that IgA targeting the Csss capsule is a critical component of local, cell-mediated antibacterial immunity.
- This mechanism offers insights into host defense strategies against meningococcal infections and potential therapeutic targets.